Caladrius Biosciences Inc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Caladrius Biosciences Inc with three other
companies in this sector in the United States:
Aratana Therapeutics Inc
sales of $38.55 million
Jounce Therapeutics Inc
Portola Pharmaceuticals Inc
Caladrius Biosciences Inc reported sales of $35.28 million
December of 2016.
increase of 56.9%
versus 2015, when the company's sales were $22.49 million.
This was the fourth straight year of sales growth at Caladrius Biosciences Inc.
Sales of Pct Segment saw an increase
57.9% in 2016, from
$22.33 million to $35.27 million.
Not all segments of Caladrius Biosciences Inc experienced an increase in sales in 2016:
sales of R&d Segment fell 90.9% to $14,000.00 .
(However, this segment's sales were only a very small portion of the company's overall sales).